Almost 95% of U.S. employers surveyed expect to see increased demand for medical services due to employees deferring care because of the pandemic. More than 90% are concerned about their employees’ long-term mental health because of COVID-19, according to a survey of 136 large employers by the Business Group on Health.
The COVID-19 pandemic is driving up demand for healthcare, and that trend could continue well into the coming years, according to a survey of major U.S. employers.
Almost 95% of those surveyed expect to see increased demand for medical services due to employees deferring care because of the pandemic. More than 90% are concerned about their employees’ long-term mental health because of COVID-19, according to a survey of 136 large employers by the Business Group on Health.
At the same time, more than three-quarters expect employees will have an increased need for help managing chronic conditions, and almost 70% expect a higher prevalence of late-stage cancers due to delayed screenings, the 2022 Large Employers’ Health Care Strategy and Plan Design Survey found.
The employers expect healthcare spending will jump about 6% both this year and next. In comparison, there was no overall change in spending last year. Employers reported a range from a 10% increase in spending for 2020, to a 12% decrease, resulting in no change overall.
To combat the mental health challenges caused by the pandemic, three-quarters of those surveyed said providing access to mental health care will be a major area of focus in 2022, and many will focus on addressing the stigma surrounding behavioral health care.
Virtual healthcare has been a major force in providing care for behavioral health issues as well as for addressing physical health concerns during the pandemic, and the use of telehealth is expected to continue next year.
At the same time, employers are expected to put an increasing emphasis on on-site healthcare clinics, which can provide COVID-19 testing and vaccinations, and help employees manage their chronic conditions.
More than 50% of those surveyed had on-site clinics by 2017, but that dropped to 44% with the start of the pandemic in 2020. Now 57% say they will have or are considering having an on-site clinic by 2024.
FDA Site Inspections Decreased During Pandemic. Questions Continue about Drug Quality.
December 4th 2023A recent study has found that FDA inspections of drug manufacturing facilities have increased since the COVID-19 health emergency but have not yet returned to pre-pandemic numbers.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
The risk of stroke is not as likely for adults 65 years and above who have taken the Pfizer-BioNTech and Moderna COVID-19 bivalent vaccines. However, there may be an elevated risk of stroke when COVID boosters are paired with high-dose flu vaccines, particularly in adults 85-years-old and above.
Read More
Prevalence of COVID-19 and Transmission Between Childcare Centers, Households is Low, Study Finds
October 26th 2023Authors of a recent JAMA Network Open study expressed there have been few reported COVID surveillance studies of childcare centers and none in the U.S. Authors stress that it's essential for policymakers to understand the real risk of COVID spread in CCCs and households so they can apply suitable mitigation measures if there were to be another surge or new variants to come about.
Read More